About US
Contact us
-
Chasing Pfizer and Lilly, Sun Pharma wins FDA nod for alopecia areata med LeqselviAfter Eli Lilly’s Olumiant won the distinction of becoming the first med approved by the FDA to treat the follicle-attacking autoimmune disease alopecia areata, Pfizer followed up with a green light2024/7/25
-
Eisai, Biogen's Alzheimer's med Leqembi turned down in Europe—but analyst says it's merely a 'delay'Despite winning approvals in a range of countries like the U.S., China, Japan and Israel, Eisai and Biogen’s anti-amyloid Alzheimer’s disease med Leqembi has come up short in the eyes of European reg2024/7/23
-
FDA advisers, frustrated by AZ's Imfinzi design, call for revamp of perioperative lung cancer trialsThe FDA’s Oncologic Drugs Advisory Committee (ODAC) has unanimously called for a revamp of perioperative clinical trial designs in resectable non-small cell lung cancer (NSCLC) to include assessment2024/7/23
-
AbbVie boosts profit outlook as Humira successors branch into gastroenterology marketWith a new chief at the helm and higher profit projections in sight, AbbVieisentering a “new chapter," CEO Robert Michael told analysts Thursday. During the second quarter, AbbViereporteda 29.8% plun2024/7/18
-
Amid Eylea clash, Roche's Vabysmo keeps climbing despite a slowdown in its momentumWhile Roche touted sales and market share increases for eye disease drug Vabysmo on Thursday, there is evidence of a slowdown of its momentum as it battles Regeneron and Bayer’s powerhouse Eylea fran2024/7/18
-
With capacity upgrades ready to roll, Sanofi stands firm on blockbuster sales goal for RSV drug in 2024While manufacturing and supply hitches have troubled the rollout of Sanofi’s key respiratory syncytial virus (RSV) drug, the near-term expected approval of a pair of new filling lines is giving the F2024/7/16
-
Ahead of adcomm, FDA pokes holes in AZ's perioperative lung cancer filing for ImfinziInterim results from a phase 3 trial of AstraZeneca’s Imfinzi as a treatment before and after surgery in resectable non-small cell lung cancer (NSCLC) were head-scratching as they failed to answer tw2024/7/16
-
Flu vaccine makers CSL Seqirus, Sanofi and GSK kick off initial shipments ahead of upcoming seasonThe dog days of summer might be infull swing, but for flu vaccine makers, its a busy time prepping for this fall's influenza season. CSL Seqirus said it kicked off influenza vaccine shipments on July2024/7/11
-
Citing manufacturing issue, FDA rejects Novo Nordisk's once-weekly insulinIn surging to the top spot in the market caprankingsin Europe, Novo Nordisk has been on an extended winning streak. But the FDA has slowed the roll for the Danish company,rejectingits once-a-week ins2024/7/11
-
Indivior slashes revenue projection and head count, drops schizophrenia medJust seven weeks after projecting an 18% revenue boost for this year, Indivior hasslashedits estimate to an 8% increase, citing competitive pressures for its opioid addiction treatment Sublocade and2024/7/9